• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic

tetano

Editor, Senior Moderator
PLoS One


. 2024 May 10;19(5):e0303176.
doi: 10.1371/journal.pone.0303176. eCollection 2024. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic

Taavi Päll[SUP] 1 [/SUP], Aare Abroi[SUP] 2 [/SUP], Radko Avi[SUP] 1 [/SUP], Heiki Niglas[SUP] 3 [/SUP], Arina Shablinskaja[SUP] 1 [/SUP], Merit Pauskar[SUP] 1 [/SUP], Ene-Ly Jõgeda[SUP] 1 [/SUP], Hiie Soeorg[SUP] 1 [/SUP], Eveli Kallas[SUP] 1 [/SUP], Andrio Lahesaare[SUP] 4 [/SUP], Kai Truusalu[SUP] 1 [/SUP], Dagmar Hoidmets[SUP] 1 [/SUP], Olga Sadikova[SUP] 3 [/SUP], Kaspar Ratnik[SUP] 4 [/SUP], Hanna Sepp[SUP] 3 [/SUP], Liidia Dotsenko[SUP] 3 [/SUP], Jevgenia Epštein[SUP] 3 [/SUP], Heleene Suija[SUP] 3 [/SUP], Katrin Kaarna[SUP] 5 6 [/SUP], Steven Smit[SUP] 7 [/SUP], Lili Milani[SUP] 7 [/SUP], Mait Metspalu[SUP] 7 [/SUP], Ott Eric Oopkaup[SUP] 8 [/SUP], Ivar Koppel[SUP] 8 [/SUP], Erik Jaaniso[SUP] 9 [/SUP], Ivan Kuzmin[SUP] 8 [/SUP], Heleri Inno[SUP] 8 [/SUP], Uku Raudvere[SUP] 8 [/SUP], Mari-Anne Härma[SUP] 3 [/SUP], Paul Naaber[SUP] 1 4 [/SUP], Tuuli Reisberg[SUP] 7 [/SUP], Hedi Peterson[SUP] 9 [/SUP], Ulvi Gerst Talas[SUP] 8 [/SUP], Irja Lutsar[SUP] 1 [/SUP], Kristi Huik[SUP] 1 [/SUP]



Affiliations
Abstract

Background: The COVID-19 pandemic was characterised by rapid waves of disease, carried by the emergence of new and more infectious SARS-CoV-2 virus variants. How the pandemic unfolded in various locations during its first two years has yet to be sufficiently covered. To this end, here we are looking at the circulating SARS-CoV-2 variants, their diversity, and hospitalisation rates in Estonia in the period from March 2000 to March 2022.
Methods: We sequenced a total of 27,550 SARS-CoV-2 samples in Estonia between March 2020 and March 2022. High-quality sequences were genotyped and assigned to Nextstrain clades and Pango lineages. We used regression analysis to determine the dynamics of lineage diversity and the probability of clade-specific hospitalisation stratified by age and sex.
Results: We successfully sequenced a total of 25,375 SARS-CoV-2 genomes (or 92%), identifying 19 Nextstrain clades and 199 Pango lineages. In 2020 the most prevalent clades were 20B and 20A. The various subsequent waves of infection were driven by 20I (Alpha), 21J (Delta) and Omicron clades 21K and 21L. Lineage diversity via the Shannon index was at its highest during the Delta wave. About 3% of sequenced SARS-CoV-2 samples came from hospitalised individuals. Hospitalisation increased markedly with age in the over-forties, and was negligible in the under-forties. Vaccination decreased the odds of hospitalisation in over-forties. The effect of vaccination on hospitalisation rates was strongly dependent upon age but was clade-independent. People who were infected with Omicron clades had a lower hospitalisation likelihood in age groups of forty and over than was the case with pre-Omicron clades regardless of vaccination status.
Conclusions: COVID-19 disease waves in Estonia were driven by the Alpha, Delta, and Omicron clades. Omicron clades were associated with a substantially lower hospitalisation probability than pre-Omicron clades. The protective effect of vaccination in reducing hospitalisation likelihood was independent of the involved clade.


 
Back
Top Bottom